Perfil del autor: Retamar Gentil, Pilar
Datos institucionales
| Nombre | Retamar Gentil, Pilar |
| Departamento | Medicina |
| Área de conocimiento | Medicina |
| Categoría profesional | Profesora Contratada Doctora (Plaza Vinc.) |
| Correo electrónico | Solicitar |
 |
|
Estadísticas
-
Nº publicaciones
29
-
Nº visitas
2471
-
Nº descargas
3940
| Publicaciones |
|---|
Artículo
 Antibiotic use and outcome in patients with negative blood cultures, a new target population for antimicrobial stewardship interventions: A prospective multicentre cohort (NO-BACT)
(Elsevier, 2024)
Objectives: To evaluate the appropriateness of antimicrobial treatment and the risk factors for mortality in patients with ... |
Artículo
Effectiveness of fosfomycin trometamol as oral step-down therapy for bacteraemic urinary tract infections due to MDR Escherichia coli: a post hoc analysis of the FOREST randomized trial
(Oxford Academic, 2023)
Background Fosfomycin is a potentially attractive option as step-down therapy for bacteraemic urinary tract infections ... |
Tesis Doctoral
Oportunidades para la optimización del tratamiento antibiótico y pronóstico en pacientes con hemocultivo negativo (Proyecto NO-BACT)
(2022)
Los pacientes con sospecha de infección y extracción de hemocultivo son un grupo clínicamente heterogéneo. Dentro de ellos, ... |
Tesis Doctoral
Programas de optimización de uso de antibióticos (PROA): evaluación de la calidad de uso de antimicrobianos e impacto de la auditoria en dos pasos desde la farmacia hospitalaria
(2022)
Introducción Los Programas de Optimización del uso de Antimicrobianos (PROA) tienen como objetivo principal mejorar los ... |
Artículo
"Pseudomonas aeruginosa" Community-Onset Bloodstream Infections: Characterization, Diagnostic Predictors, and Predictive Score Development-Results from the PRO-BAC Cohort
(MDPI, 2022)
Community-onset bloodstream infections (CO-BSI) caused by gram-negative bacilli are common and associated with significant ... |
Artículo
Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections A Randomized Clinical Trial
(Jama Nerwork Open, 2022)
Importance The consumption of broad-spectrum drugs has increased as a consequence of the spread of multidrug-resistant ... |
Artículo
Effect of Combination Antibiotic Empirical Therapy on Mortality in Neutropenic Cancer Patients with Pseudomonas aeruginosa Pneumonia
(MDPI, 2022)
To assess the effect of combination antibiotic empirical therapy on 30-day case-fatality rate in neutropenic cancer patients ... |
Artículo
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)
(Wiley-Blackwell, 2022)
Scope: These ESCMID guidelines address the targeted antibiotic treatment of third-generation cepha losporin-resistant ... |
Artículo
Autoantibodies against type I IFNs in patients with critical influenza pneumonia
(ROCKEFELLER UNIV PRESS, 2022)
Autoantibodies neutralizing type I interferons (IFNs) can underlie critical COVID-19 pneumonia and yellow fever vaccine disease. ... |
Artículo
Pseudomonas aeruginosa Community-Onset Bloodstream Infections: Characterization, Diagnostic Predictors, and Predictive Score Development—Results from the PRO-BAC Cohort
(MDPI, 2022)
Community-onset bloodstream infections (CO-BSI) caused by gram-negative bacilli are common and associated with significant ... |
Artículo
Predictors of inappropriate antimicrobial prescription: Eight-year point prevalence surveys experience in a third level hospital in Spain
(Frontiers Media S.A., 2022)
Antibiotic stewardship programs (ASP) have already demonstrated clinical benefits. We aimed to describe the Point Prevalence ... |
Artículo
Preface
(Oxford University Press, 2021)
As this is the first Supplement produced by JAC-Antimicrobial Resistance (JAC-AMR) we thought it would be helpful for readers for us to briefly outline our vision and intention for these Supplements. (extract) |
Artículo
Hospital antibiotic prescribing patterns in adult patients according to the WHO Access, Watch and Reserve classification (AWaRe): results from a worldwide point prevalence survey in 69 countries
(Oxford University Press, 2021)
Objectives The WHO Access, Watch and Reserve (AWaRe) classification has been developed to support countries and hospitals ... |
Artículo
Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study
(Elsevier, 2021)
Background The clinical presentation of COVID-19 in patients admitted to hospital is heterogeneous. We aimed to determine ... |
Artículo
Temocillin versus meropenem for the targeted treatment of bacteraemia due to third-generation cephalosporin-resistant Enterobacterales (ASTARTÉ): protocol for a randomised, pragmatic trial
(BMJ Publishing Group, 2021)
Introduction: Alternatives to carbapenems are needed in the treatment of third-generation cephalosporin-resistant ... |
Artículo
Pharmacokinetics and safety of aztreonam/avibactam for the treatment of complicated intra-abdominal infections in hospitalized adults: results from the REJUVENATE study
(Oxford University Press, 2020)
Objectives: To investigate pharmacokinetics (PK) and safety (primary objectives) and efficacy (secondary objective) of the ... |
Trabajo Fin de Grado
Análisis de la calidad de la prescripción de antibióticos al alta en pacientes quirúrgicos
(2020)
Los antibióticos sirven tanto para curar infecciones como para prevenir complicaciones infecciosas relacionadas con ... |
Artículo
Opportunities for antibiotic optimisation and outcome improvement in patients with negative blood cultures: study protocol for a cluster-randomised crossover trial, the NO-BACT study.
(2018)
Introduction Patients with negative blood cultures (BCx) represent 85%–90% of all patients with BCx taken during hospital ... |
Artículo
Análisis de la calidad de uso de antimicrobianos en el servicio de urgencias de un hospital de tercer nivel
(Sanidad Ediciones, 2018)
Objetivo. Describir los factores modificables relacionados con el tratamiento antimicrobiano (TA) inadecuado en el área ... |
Artículo
Targeted Simplification Versus Antipseudomonal Broad-Spectrum Beta-Lactams in Patients With Bloodstream Infections Due to Enterobacteriaceae (SIMPLIFY): A Study Protocol for a Multicentre, Open-Label, Phase III Randomised, Controlled, Non-Inferiority Clinical Trial.
(2017)
Introduction Within the context of antimicrobial stewardship programmes, de-escalation of antimicrobial therapy is one of ... |
Trabajo Fin de Grado
Análisis de la calidad de uso de piperacilina/tazobactam en un hospital de tercer nivel
(2017)
El antibiótico piperacilina/tazobactam es un antibiótico de amplio espectro que cubre bacterias gram-negativas incluidas ... |
Artículo
Is reduced vancomycin susceptibility a factor associated with poor prognosis in MSSA bacteraemia?
(Oxford University Press, 2015)
Objectives: The known data about the influence of vancomycin MIC on Staphylococcus aureus bacteraemia are contradictory. ... |
Artículo
Predictors of early mortality in very elderly patients with bacteremia: a prospective multicenter cohort
(Elsevier, 2014)
Objectives: The proportion of very elderly people in the population is increasing, and infectious diseases in this patient ... |
Artículo
Impact of the MIC of Piperacillin-Tazobactam on the Outcome of Patients with Bacteremia Due to Extended-Spectrum-B-Lactamase- Producing Escherichia coli
(American Society for Microbiology, 2013)
We investigated the impact of the piperacillin-tazobactam MIC in the outcome of 39 bloodstream infections due to ... |
Artículo
Reappraisal of the outcome of healthcare-associated and community-acquired bacteramia: a prospective cohort study
(BioMed Central, 2013)
Background: Healthcare-associated (HCA) bloodstream infections (BSI) have been associated with worse outcomes, in terms ... |
Artículo
β-Lactam/β-Lactam Inhibitor Combinations for the Treatment of Bacteremia Due to Extended-Spectrum β-Lactamase-Producing Escherichia coli: A Post Hoc Analysis of Prospective Cohorts
(Oxford University Press, 2012)
Background. Extended-spectrum ß-lactamase–producing Escherichia coli (ESBL-EC) is an important cause of invasive infections. ... |
Artículo
Impact of Inadequate Empirical Therapy on the Mortality of Patients with Bloodstream Infections: a Propensity Score-Based Analysis
(American Society for Microbiology, 2012)
The impact of the adequacy of empirical therapy on outcome for patients with bloodstream infections (BSI) is key for ... |
Artículo
Epidemiology and clinical features of community-acquired, healthcare-associated and nosocomial bloodstream infections in tertiary-care and community hospitals
(Elsevier, 2010)
Classification of bloodstream infections (BSIs) as community-acquired (CA), healthcare-associated (HCA) and hospital-acquired ... |
Tesis Doctoral
Estudio pronóstico de una cohorte de Bacteriemias en función de su adquisición Morbilidad, Mortalidad y Factores Asociados
(2010)
Entre un 0,5% y un 1,3% de los pacientes ingresados en nuestro medio desarrollan un episodio de bacteriemia durante su ... |